Skip to main content

Table 3 Results of the CCT according to median Na + Intake

From: The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population

Ā 

APA and IHA

PH and NC

Below median (nā€‰=ā€‰54)

Above median (nā€‰=ā€‰53)

Below median (nā€‰=ā€‰102)

Above median (nā€‰=ā€‰101)

Urine sodium (mmol/24ā€‰h)

106.3ā€‰Ā±ā€‰30.0

247.6ā€‰Ā±ā€‰76.7A

109.4ā€‰Ā±ā€‰27.7

205.5ā€‰Ā±ā€‰41.5A

Pre-PAC (ng/dl)

17.7ā€‰Ā±ā€‰5.9

17.4ā€‰Ā±ā€‰5.0

13.6ā€‰Ā±ā€‰4.0

13.4ā€‰Ā±ā€‰4.2

Pre-PRA (ng/ml.h)

0.20 (0.048~0.42)

0.23 (0.065~0.35)

2.2 (0.96~3.7)

2.3 (1.2~3.7)

Pre-ARR

63.1 (45.1~300.4)

81.5 (48.0~165.2)

6.8 (3.7~13.1)

5.9 (3.5~10.1)

Post-PAC (ng/dl)

17.2ā€‰Ā±ā€‰5.7

16.4ā€‰Ā±ā€‰5.0

12.1ā€‰Ā±ā€‰4.0

12.2ā€‰Ā±ā€‰4.3

Post-PRA (ng/ml.h)

0.28 (0.050~0.62)

0.31 (0.18~0.49)

3.4 (1.6~6.1)

3.0 (1.8~5.0)

Post-ARR

50.1 (28.5~223.3)

52.0 (32.1~89.9)

3.1 (1.9~7.2)

3.7 (2.2~6.9)

PAC suppression percentage (%)

3.7 (āˆ’8.1~11.8)

3.4 (āˆ’6.1~13.3)

12.9 (āˆ’0.73~20.3)

7.9 (āˆ’3.0~21.9)

PRA incretion percentage (%)

25.1 (āˆ’21.3~102.3)

50.5 (0.0~129.0)

55.0 (9.3~158.0)

53.0 (10.1~112.1)

  1. APā€‰<ā€‰0.01 vs. below median